Trial Profile
Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2018
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 14 Apr 2018 Primary endpoint has not been met. (HVPG (Hepatic Venous Pressure Measurement)) as per results presented at The International Liver Congress 2018
- 14 Apr 2018 Results presented at The International Liver Congress 2018
- 17 Jan 2018 Status changed from recruiting to discontinued.